|
TMED5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.80989999998671E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69120000004241E-06 |
| Normal-vs-Stage2 |
2.817900E-02 |
| Normal-vs-Stage3 |
2.277900E-03 |
| Normal-vs-Stage4 |
8.91880014286528E-10 |
| Stage1-vs-Stage2 |
3.499200E-01 |
| Stage1-vs-Stage3 |
7.641200E-01 |
| Stage1-vs-Stage4 |
3.781000E-03 |
| Stage2-vs-Stage3 |
3.678000E-01 |
| Stage2-vs-Stage4 |
1.429820E-02 |
| Stage3-vs-Stage4 |
2.401000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.76660000001028E-06 |
| Normal-vs-AfricanAmerican |
1.17470033700329E-10 |
| Normal-vs-Asian |
7.114100E-02 |
| Caucasian-vs-AfricanAmerican |
4.988600E-04 |
| Caucasian-vs-Asian |
9.102600E-01 |
| AfricanAmerican-vs-Asian |
1.555380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.22789999951389E-07 |
| Normal-vs-Female |
2.780600E-04 |
| Male-vs-Female |
1.520990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.817170E-04 |
| Normal-vs-Age(41-60Yrs) |
1.78109999999787E-05 |
| Normal-vs-Age(61-80Yrs) |
3.53250000000305E-05 |
| Normal-vs-Age(81-100Yrs) |
1.419700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.962600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.217200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.836800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.664200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.779200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.775600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.564100E-02 |
| Normal-vs-Grade 2 |
2.022100E-03 |
| Normal-vs-Grade 3 |
1.29340005372569E-09 |
| Normal-vs-Grade 4 |
1.02590003159264E-09 |
| Grade 1-vs-Grade 2 |
9.891800E-01 |
| Grade 1-vs-Grade 3 |
3.311200E-01 |
| Grade 1-vs-Grade 4 |
7.298300E-02 |
| Grade 2-vs-Grade 3 |
9.209600E-02 |
| Grade 2-vs-Grade 4 |
3.321400E-03 |
| Grade 3-vs-Grade 4 |
3.965700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.022600E-03 |
| Normal-vs-ccB subtype |
1.244440E-04 |
| ccA subtype-vs-ccB subtype |
1.048400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.968500E-04 |
| Normal-vs-N1 |
1.235780E-02 |
| N0-vs-N1 |
7.410200E-01 |
|
|
